KAROLINSKA UNIVERSITY HOSPITAL – SEMMELWEIS UNIVERSITY
We are proud to announce the Second Semmelweis-Karolinska bilateral symposium November 11-12, Department of Pathology, Semmelweis University, Budapest. The program for this symposium is extensive and covers a wide range within Pathology from basic science to clinical science and education at basic, advanced and specialist levels. A special session is dedicated to Covid-19. The symposium is a tribute to and a result of the extensive and fruitful collaboration between the Pathology departments of the Semmelweis University, Karolinska Institutet and Karolinska University Hospital which has continued and developed since more than a decade for the benefit of all three institutions.
Elimination of Cervical Cancer and the Role of Human Papillomavirus Genotyping
Joakim Dillner Clinical Pathology and Cancerdiagnostics, Medical Diagnostics Karolinska, Karolinska University Hospital
Joakim Dillner is professor of infectious disease epidemiology of the Karolinska Institutet in Stockholm. He is also Scientific Director of Medical Diagnostics Karolinska and head of their Cervical Cancer Prevention Center. He has initiated international randomized trials on HPV screening as well as Nordic biobank and registry-based follow-up studies of the effectiveness of HPV vaccines.
He is leading the International Papillomavirus Reference Center (www.hpvcenter.se), the Swedish National Quality Registry of Cervical Cancer Prevention and the Nordic Information for Action eScience Center of Excellence (www.nordicehealth.se). He is coordinating the H2020 project HEAP (Human Exposome Assessment Platform), where an AI-driven data platform to evaluate the impact of the internal and external exposome on health is being developed and is also PI in the H2020 project RISCC (Risk-based screening for cervical cancer). He has authored more than 550 publications in the areas of cancer screening, vaccination, tumor virology, epidemiology, and research infrastructures. During the Corona pandemic the spread of SARS-CoV-2 among healthcare professionals, and how vaccination against the virus protects against infection and the spread of infection, have been mapped.
Immunogenic Mimicry of Melanoma and Other Cancers
József Tímár Department of Pathology, Forensic and Insurance Medicine, Semmelweis University
Professor Tímár started his carier at Semmelweis University, 1st Department of Pathology as student teacher in 1974 than became a pathology resident in 1976, specialized in pathology in 1980. Rearly on he engaged in cancer research interested in metastatization of tumors. He became professor of pathology in 1994. From 1999 for a decade he worked at the National Institute of Oncology, Budapest as director of Tumor Progression Laboratory. From 2008 till 2017 he was the director of the 2nd Department of Pathology. His research focused on melanoma progression and tumor immmunology of oral cancers. Recently his group is involved in development of mutant KRAS inhibitors. He is the founder and chief Editor of the Journal Pathology Oncology Research. He has more than 300 international publications with citations of more than 7000. He was tutor of 18 PhD students.